Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure (Q45120611)
scientific article published in November 2004
Language:
(P31) (Q13442814)
(P50) (Q46618620)
(Q51140505)
(P304) 1509-1516
(P407) (Q1860)
(P433) 11
(P478) 13
(P577) Monday, November 1, 2004
(P1433) (Q5421208)
(P1476) "Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure" (language: en)
(P2093) Ronald S Freudenberger
Richard P Schwarz
Joanne Brown
Alan Moore
Michael M Givertz
Joshua M Hare
(P2860) (Q34045219)
(Q44411390)
(Q44411386)
(Q43696104)
(Q44365406)
(Q27863312)
(Q44015014)
(Q44243299)
(Q44053746)
(Q43797629)
(Q45173363)
(Q31825825)
(Q44590286)
(Q36093533)
(Q34524008)
other details
description scientific article published in November 2004

External Links